
Meet the Scientist: Christian Vettermann, Ph.D.
In his latest paper, Dr. Vettermann solves a complex problem facing hemophilia A scientists and clinicians for years.
Explore Topics
Christian Vettermann is a Principal Scientist who joined BioMarin in 2015 to lead the bioanalytical team for hemophilia A gene therapy research. The group develops and validates test methods to measure biomarkers, antibodies, and drug concentrations to support efficacy and safety evaluations in clinical and non-clinical studies.
In his latest paper, Dr. Vettermann solves a complex problem facing hemophilia A scientists and clinicians for years.